西藏药业股价跌5.05%，华夏基金旗下1只基金位居十大流通股东，持有190.36万股浮亏损失451.16万元

Group 1 - The core point of the news is that Tibet Pharmaceutical has experienced a significant decline in its stock price, dropping 5.05% on October 23, with a total market value of 14.366 billion yuan [1] - Tibet Pharmaceutical's stock has fallen for four consecutive days, with a cumulative decline of 4.63% during this period [1] - The company primarily engages in pharmaceutical manufacturing, with 99.80% of its revenue coming from drug sales and only 0.20% from other sources [1] Group 2 - Among the top shareholders of Tibet Pharmaceutical, one fund from Huaxia Fund holds 1.9036 million shares, representing 0.59% of the circulating shares [2] - The Huaxia Industry Prosperity Mixed A fund has incurred a floating loss of approximately 4.5116 million yuan today, with a total floating loss of 4.3403 million yuan over the past four days [2] - The fund has achieved a return of 51.13% year-to-date and 55.43% over the past year, ranking 757 out of 8159 and 489 out of 8030 respectively [2]